Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Oncogene ; 33(1): 74-84, 2014 Jan 02.
Article in English | MEDLINE | ID: mdl-23178499

ABSTRACT

Leptin acts on its receptor (ObR) in the hypothalamus to inhibit food intake and energy expenditure. Leptin and ObR are also expressed in the gastrointestinal tract; however, the physiological significance of leptin signaling in the gut remains uncertain. Suppressor of cytokine signaling 3 (SOCS3) is a key negative feedback regulator of ObR-mediated signaling in the hypothalamus. We now show that gastrointestinal epithelial cell-specific SOCS3 conditional knockout (T3b-SOCS3 cKO) mice developed gastric tumors by enhancing leptin production and the ObRb/signal transducer and activator of transcription 3 (STAT3) signaling pathway. All T3b-SOCS3 cKO mice developed tumors in the stomach but not in the bowels by 2 months of age, even though the SOCS3 deletion occurred in both the epithelium of stomach and bowels. The tumors developed in the absence of the inflammatory response and all cKO mice died within 6 months. These tumors displayed pathology and molecular alterations, such as an increase in MUC2 (Mucin 2, oligomeric mucus/gel-forming) and TFF3 (trefoil factor 3), resembling human intestinal-type gastric tumors. Administration of antileptin antibody to T3b-SOCS3 cKO mice reduced hyperplasia of gastric mucosa, which is the step of the initiation of gastric tumor. These data suggest that SOCS3 is an antigastric tumor gene that suppresses leptin overexpression and ObRb/STAT3 hyperactivation, supporting the hypothesis that the leptin/ObRb/STAT3 axis accelerates tumorigenesis and that it may represent a new therapeutic target for the treatment of gastric cancer.


Subject(s)
Adenocarcinoma/metabolism , Receptors, Leptin/metabolism , Stomach Neoplasms/metabolism , Suppressor of Cytokine Signaling Proteins/deficiency , Adenocarcinoma/drug therapy , Animals , Antibodies/administration & dosage , Antineoplastic Agents/administration & dosage , Carcinogenesis/metabolism , Cells, Cultured , Disease Models, Animal , Drug Evaluation, Preclinical , Gastric Mucosa/metabolism , Humans , Injections, Intraperitoneal , Intestinal Mucosa/metabolism , Leptin/antagonists & inhibitors , Leptin/immunology , Mice , Mice, Transgenic , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/metabolism , Protein Kinases/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Stomach/pathology , Stomach Neoplasms/drug therapy , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics
2.
Reprod Domest Anim ; 45(1): 50-4, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19144025

ABSTRACT

We investigated the effects of twice-weekly follicular punctures of ovaries with or without corpus luteum (CL) on follicular and luteal dynamics. A cross-over design was used, with each cow (seven Japanese Black beef cows) being assigned to one of the three groups at 2-month intervals. Follicular punctures were performed twice weekly for three consecutive weeks until day 20 (oestrus = day 0). All visible follicles (diameter >3 mm) in the ovaries bearing CL (ipsilateral group) or those in the contralateral ovaries (contralateral group) were aspirated. As a control, all visible follicles in both ovaries were aspirated (bilateral group). Follicular development, CL formation and progesterone concentrations in each cow were monitored from days 0 to 30. Follicular growth profiles in the punctured ovaries during/after puncture treatment were similar, irrespective of the presence of follicles in the unpunctured ovary and the CL in the punctured or unpunctured ovaries. After puncture, two cows (28.6%) each in the ipsilateral and bilateral groups did not exhibit behavioural oestrus until day 30, whereas all cows in the contralateral group exhibited oestrus. CL growth and increase in progesterone concentrations after the last follicular puncture in the bilateral group were delayed when compared with those in the ipsilateral group. Our results indicate that the presence of follicles in the unpunctured ovary and the CL in the punctured or unpunctured ovaries does not significantly influence follicular growth in punctured ovaries during/after puncture treatment. However, follicular puncture in ovaries bearing CL may disturb or delay oestrus occurrence after treatment.


Subject(s)
Cattle , Corpus Luteum/physiology , Ovarian Follicle/physiology , Ovary/physiology , Punctures/veterinary , Animals , Corpus Luteum/diagnostic imaging , Corpus Luteum/growth & development , Female , Ovarian Follicle/diagnostic imaging , Ovary/diagnostic imaging , Progesterone/blood , Punctures/adverse effects , Tissue and Organ Harvesting/methods , Tissue and Organ Harvesting/veterinary , Ultrasonography
3.
Br J Cancer ; 98(4): 824-31, 2008 Feb 26.
Article in English | MEDLINE | ID: mdl-18268498

ABSTRACT

SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27(Kip1) level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation (P=0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.


Subject(s)
Apoptosis , Cell Proliferation , DNA-Binding Proteins/metabolism , Gene Silencing , HMGB Proteins/metabolism , Stomach Neoplasms/metabolism , Transcription Factors/metabolism , Blotting, Western , Caspases/metabolism , Cell Cycle , Cyclin-Dependent Kinase Inhibitor p27 , DNA Methylation , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/genetics , Down-Regulation , Flow Cytometry , HMGB Proteins/antagonists & inhibitors , HMGB Proteins/genetics , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Phosphorylation , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/pharmacology , Retinoblastoma Protein , Reverse Transcriptase Polymerase Chain Reaction , SOXB1 Transcription Factors , Stomach Neoplasms/pathology , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Tumor Cells, Cultured
4.
Eur Surg Res ; 40(3): 247-55, 2008.
Article in English | MEDLINE | ID: mdl-18057903

ABSTRACT

BACKGROUND/AIM: Ischemic preconditioning (IPC) may reduce hepatic ischemia-reperfusion (IR) injury, but efficacy of IPC on mitochondrial proteome is not demonstrated. We investigated how IPC modifies the mitochondrial proteome after IR injury. METHODS: Rats were subjected to 25 min of portal triad crossclamping (IR group, n = 8). In the IPC group (n = 8), 10 min of temporal portal triad clamping was performed before 25 min of portal clamping. Samples were obtained after 24 h. The mitochondrial inner-membrane potential was measured by the uptake of a lipophilic cationic carbocyanine probe and mitochondrial proteome was also investigated using 2-dimensional differential in-gel electrophoresis and liquid chromatography-tandem mass spectrometry. RESULTS: Mitochondrial inner-membrane potential and glutathione were lower and serum transaminase was higher in the IPC group than in the IR group. The mitochondrial precursor of aldehyde dehydrogenase 2 and alpha-methylacyl-CoA-racemase were upregulated in the IPC group in comparison to the IR group. In contrast, protein disulfide-isomerase A3 precursor, 60S acid ribosomal protein P0, carbonic anhydrase 3 and superoxide dismutase were significantly more downregulated in the IPC group than in the IR group. CONCLUSIONS: A hepatoprotective effect by IPC was not shown; however, IPC caused significant up- or downregulation of several mitochondrial proteins.


Subject(s)
Ischemic Preconditioning , Liver Diseases/prevention & control , Mitochondria, Liver/physiology , Proteome/physiology , Reperfusion Injury/prevention & control , Animals , Disease Models, Animal , Liver Diseases/physiopathology , Male , Rats , Rats, Wistar , Reperfusion Injury/physiopathology
5.
Transplant Proc ; 39(10): 3007-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18089310

ABSTRACT

The present study demonstrated the feasibility of monitoring nitric oxide (NO) and pO2 levels under ischemic conditions associated with small bowel ischemia/reperfusion (I/R) injury through the use of selective electrodes for NO and oxygen molecules. NO levels gradually increased during ischemia. When reperfusion was started, the NO level decreased suddenly and returned to pre-ischemia values within 10 minutes. After clamping, pO2 decreased rapidly. When reperfusion was started, pO2 increased suddenly, returning to pre-ischemia values within 10 minutes. We concluded that it is feasible to monitor NO and pO2 levels under ischemic conditions of small bowel I/R injury through the use of electrodes selective for NO and oxygen molecules.


Subject(s)
Intestine, Small/blood supply , Nitric Oxide/metabolism , Oxygen Consumption , Oxygen/metabolism , Reperfusion Injury/metabolism , Animals , Biomarkers/analysis , Disease Models, Animal , Electrodes , Male , Monitoring, Physiologic/methods , Nitric Oxide/analysis , Oxygen/analysis , Rats , Rats, Sprague-Dawley
6.
Transplant Proc ; 39(10): 3002-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18089309

ABSTRACT

BACKGROUND: Reperfusion of ischemic tissues results in the formation of toxic reactive oxygen species (ROS), such as superoxide anion, hydroxyl radicals, hydroperoxide, and peroxynitrite. ROS are potent oxidizing agents, capable of damaging cellular membranes by lipid peroxidation. In the present study, we applied an in vivo electron paramagnetic resonance (EPR)/spin probe and an ex vivo EPR technique to provide direct evidence of ROS following experimentally induced small bowel ischemia/reperfusion (I/R) injury. MATERIALS AND METHODS: We used a rat model of small bowel I/R injury to explore the possibility that MnM2Py4P or Mn-salen can prevent the accumulation of ROS species following experimentally induced I/R injury. We examined the ability of MnM2Py4P and Mn-salen to scavenge radicals in living Sprague-Dawley (SD) rats using an in vivo and an ex vivo EPR technique with a spin probe. RESULTS: The CP decay rates in the MnM2Py4P- and Mn-salen-treated rats were significantly higher than those in the untreated rats and almost equal to those in sham group rats. There were no significant differences between the MnM2Py4P-treated group and the Mn-salen-treated group. Superoxide scavenging activities (SSA) in the MnM2Py4P- and EUK-8-treated group were higher than those in the untreated group and almost equal to the sham group. CONCLUSION: The present study suggested that the protective effects of MnM2Py4P and Mn-salen against small bowel IR injury were mediated by the inhibition of O2, H2O2, and NO production.


Subject(s)
Antioxidants/therapeutic use , Ethylenediamines/therapeutic use , Intestine, Small/blood supply , Intestine, Small/injuries , Metalloporphyrins/therapeutic use , Reperfusion Injury/prevention & control , Animals , Cyclic N-Oxides/metabolism , Electron Spin Resonance Spectroscopy , Rats , Reperfusion Injury/pathology
7.
Pharmacopsychiatry ; 38(1): 30-5, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15706464

ABSTRACT

OBJECTIVE: The aim of this study was to compare the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. METHODS: The efficacy and safety profiles of fluvoxamine, a selective serotonin-reuptake inhibitor, and nortriptyline were compared under a single-blind fashion in 74 Japanese patients with major depression. The efficacy was assessed using the 17-item Hamilton Rating Scale for Depression (HAM-D), Clinical Global Impression Scale (CGI) severity and improvement scores, while the safety profiles were assessed using the UKU Side Effect Rating Scale at baseline, and on days 7, 14, 28 and 56. Moreover, with the aim of determining the distinct efficacy profiles of each drug, the effects on each of the factor scores extracted by the principal component analysis performed for HAM-D scores were compared between drugs. RESULTS: Both drug groups showed significant amelioration of depressive symptomatology over the trial period lasting for 8 weeks. Statistical analyses revealed no significant between-group differences regarding the efficacy assessed by either HAM-D or CGI scores; however, the efficacy of nortriptyline tended to appear earlier than that of fluvoxamine. Moreover, no significant differences were obtained for the factor scores, representing 'depressed mood', 'physical symptoms' or 'sleep disturbances', although 'sleep disturbances' appeared to improve earlier in the nortriptyline group than in the fluvoxamine group. As for the safety profiles, the nortriptyline group scored a significantly higher incidence of adverse events such as dysarthria or orthostatic dizziness, as well as increased heart rate. CONCLUSIONS: These findings suggest that fluvoxamine is generally comparable to nortriptyline in its efficacy and superior in its safety profile, in accordance with findings obtained in previous comparative clinical trials conducted in Caucasian populations.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Antidepressive Agents, Tricyclic/therapeutic use , Depressive Disorder, Major/drug therapy , Fluvoxamine/therapeutic use , Nortriptyline/therapeutic use , Adult , Aged , Antidepressive Agents, Second-Generation/adverse effects , Antidepressive Agents, Tricyclic/adverse effects , Depressive Disorder, Major/psychology , Double-Blind Method , Female , Fluvoxamine/adverse effects , Humans , Japan , Male , Middle Aged , Nortriptyline/adverse effects , Psychiatric Status Rating Scales
8.
J Hepatobiliary Pancreat Surg ; 8(4): 383-6, 2001.
Article in English | MEDLINE | ID: mdl-11521186

ABSTRACT

We present a rare case of eight multicentric hepatocellular carcinomas (HCCs) occurring in the same segment of the liver. In a 66-year-old Japanese man, multiple liver tumors were detected during follow-up of chronic hepatitis C infection, and he was admitted to our hospital in 1995. Ultrasonography (US) showed eight tumors, each measuring between 10 and 15 mm in diameter, in the right lobe, and a 10-mm tumor in the left lobe. Angio-ultrasonography (US) showed no enhancement of the tumors, and multicentric occurrence was suspected. Portal angio-US showed eight tumors in the right lobe located in the anterior segment. Accordingly, anterior segmentectomy and partial resection of the S3 subsegment were performed, in December, 1995. On histological examination, all eight tumors in the anterior segment and the tumor in the S3 subsegment were well differentiated HCC. The liver parenchyma showed cirrhosis. The grade and stage of hepatitis did not differ between the anterior segment and the S3 subsegment, but irregular regeneration of hepatocytes was more prominent in the anterior segment. The multicentric occurrence of HCCs in the anterior segment may be related to the more severe damage caused by chronic hepatitis in the anterior segment than in the left lobe of the liver.


Subject(s)
Carcinoma, Hepatocellular/diagnosis , Liver Neoplasms/diagnosis , Neoplasms, Multiple Primary/diagnosis , Aged , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/surgery , Hepatitis C, Chronic/complications , Humans , Liver/diagnostic imaging , Liver/surgery , Liver Cirrhosis/complications , Liver Neoplasms/complications , Liver Neoplasms/surgery , Male , Neoplasms, Multiple Primary/complications , Neoplasms, Multiple Primary/surgery , Radiography , Ultrasonography
9.
J Hepatobiliary Pancreat Surg ; 8(2): 154-7, 2001.
Article in English | MEDLINE | ID: mdl-11455472

ABSTRACT

We aimed to assess the patterns of recurrence after surgery for intrahepatic cholangiocarcinoma (ICC) and the outcomes of treatment in patients with recurrence. From 1981 to 1999, 123 patients with ICC underwent hepatectomy. The 3-year and 5-year survival rates were significantly higher in patients after curative resection (n = 56; 53%, 50%) than in patients after noncurative resection (n = 67; 7%, 2%; P < 0.0001). In 54 patients followed-up after curative resection, the rate of recurrence after surgery was 46%. The recurrences were in the liver (56%), abdomen (disseminated; 24%), and lymph nodes (20%). The rates of recurrence were significantly higher in patients with various classifications of mass-forming ICC tumors (P = 0.039) than in those with other types of tumors, and in patients with tumors over 3 cm in greatest diameter than in those with tumors 3 cm or less (P = 0.006). Hepatic recurrence, abdominal dissemination, and intraductal recurrence were significantly related to tumors that included mass-forming ICC (P = 0.002), tumors that included periductal infiltrating ICC (P = 0.009), and tumors that included intraductal growth ICC (P = 0.038), respectively. Seven patients with recurrence underwent radiation, chemotherapy, immunotherapy, or surgical resection. Only 2 patients, with intrahepatic metastasis and intraductal recurrence, respectively, had good outcomes after surgery. The effectiveness of other treatments has not been established.


Subject(s)
Bile Duct Neoplasms/pathology , Bile Duct Neoplasms/surgery , Bile Ducts, Intrahepatic , Cholangiocarcinoma/secondary , Cholangiocarcinoma/surgery , Abdominal Neoplasms/secondary , Aged , Female , Humans , Liver Neoplasms/secondary , Lymphatic Metastasis , Male , Middle Aged
12.
Chem Pharm Bull (Tokyo) ; 49(4): 507-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11310687

ABSTRACT

Cycloenantiomeric hexahomooxacalix[3]arenes with different substituents on the three upper rims were synthesized for the first time by fixing their conformation into a cone. A cycloenantiomeric hexahomooxacalix[3]arene 6 was resolved into both enantiomeric forms and chiroptically characterized. Preliminary 1H-NMR studies indicated that the optically resolved cycloenantiomer 6 could discriminate the enantiomers of hydrochloride of phenylalanine ethyl ester.


Subject(s)
Phenols/chemistry , Chromatography, High Pressure Liquid , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Conformation , Molecular Structure , Phenols/chemical synthesis
13.
Chem Commun (Camb) ; (18): 1830-1, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-12240336

ABSTRACT

Self-assembled monolayers of a tripod-shaped conjugated-thiol grafted onot Au(111) substrates are found to show electrochemically reversible oxidation and reduction and to improve electroluminescence performances of organic light-emitting diodes.

14.
Nihon Hinyokika Gakkai Zasshi ; 91(9): 611-7, 2000 Sep.
Article in Japanese | MEDLINE | ID: mdl-11068424

ABSTRACT

BACKGROUND AND PURPOSE: Depression is well known as one of the psychiatric complications of interferon (IFN) therapy in patients with chronic active hepatitis C. We compared the psychiatric status during interferon therapy between patients with renal cell cancer (RCC) and those with chronic active hepatitis C. METHODS: The psychiatric status of 40 patients with renal cell cancer, 36 who were subjected to radical nephrectomy and 4 who were not because of the presence of distant metastasis and other complicated underlying diseases, was assessed by psychiatrists before and at 2, 4, 12 and 24 weeks after the start of IFN therapy according to the major depressive episode diagnostic criteria listed in the DSM-III-R and the Hamilton Depression Scale (HDS). The mental aspect was measured using the Eysenk Personality Questionnaire (EPQ) before IFN therapy, and the results were compared with those obtained in 85 hepatitis C patients evaluated according to the same protocol for psychiatric assessment. RESULTS: Eight of the 40 patients were diagnosed as having depression before IFN therapy and 5 of them became even more depressed 2 weeks after the start of IFN therapy. Nine patients were found to be depressed after the start of IFN therapy, 7 of them were diagnosed before 4 weeks of therapy. All the patients needed treatment for depression: discontinuation of IFN therapy in 4, decrement of the IFN dose in 8, and psychiatric drug medication in 13. The patients who suffered from depression had significantly higher scores in neuroticism (EPQ) before IFN therapy than those who did not become depressed. There was no difference in age, sex or cancer stage between the two groups. The occurrence of depression in RCC patients was the same as that observed in hepatitis C patients receiving IFN therapy. But in RCC patients the depressive state was diagnosed earlier and was more severe than that observed in hepatitis C patients. CONCLUSION: Urologists should be aware of the psychiatric symptoms of RCC patients under IFN therapy just as in hepatitis patients. The depression in RCC patients was considered to be related to the cancerous disease itself which may explain its higher degree of severity, as compared to hepatitis C patients.


Subject(s)
Antineoplastic Agents/adverse effects , Carcinoma, Renal Cell/drug therapy , Carcinoma, Renal Cell/psychology , Depression/chemically induced , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/psychology , Interferon-alpha/adverse effects , Kidney Neoplasms/drug therapy , Kidney Neoplasms/psychology , Aged , Antineoplastic Agents/administration & dosage , Female , Humans , Interferon-alpha/administration & dosage , Male , Middle Aged
16.
Chem Pharm Bull (Tokyo) ; 48(6): 882-4, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10866155

ABSTRACT

Several homooxacalix[3]arenes possessing different substituents on their upper rims were synthesized in yields of 7-20% by a condensation reaction between the p-substituted-phenol dimer and monomer under acidic high-dilution conditions.


Subject(s)
Macromolecular Substances , Calixarenes , Molecular Structure , Spectrum Analysis
17.
J Gastroenterol ; 35 Suppl 12: 38-41, 2000.
Article in English | MEDLINE | ID: mdl-10779216

ABSTRACT

Helicobacter pylori and nonsteroidal antiinflammatory drugs (NSAIDs) are considered the major causes of peptic ulcer. If ulcers are not attributable to H. pylori, most are thought to be attributable to NSAIDs. We have previously reported that rheumatoid arthritis (RA) patients taking NSAIDs long term (NSAIDs group) are more likely to develop gastric ulcers, which commonly occur in the gastric antrum. In addition, the morphology of gastric ulcers in the NSAIDs group differs from that in the non-NSAIDs group (control group), in whom NSAIDs are not involved in the occurrence of gastric ulcers. In this study, we compared gastric ulcers in the NSAIDs group with those in the control group in terms of H. pylori infection. The positive rate of H. pylori in gastric ulcers was significantly lower in the NSAIDs group than in control group (53.6% vs 91.5%). At the ulcer site they were seen significantly less often in the antrum than in either the angle or body of the stomach (35% vs 100%) in the NSAIDs group. On the other hand, the H. pylori-positive rate for ulcers in the antrum did not differ significantly from that in the angle and body of the stomach (81.8% vs 93.8%) in the control group. These findings suggest that H. pylori plays little role in antral ulcers in those taking NSAIDs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Arthritis, Rheumatoid/drug therapy , Helicobacter Infections/diagnosis , Helicobacter pylori , Stomach Ulcer/chemically induced , Adult , Aged , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Female , Humans , Male , Middle Aged , Risk Factors , Stomach Ulcer/microbiology
18.
Epilepsy Res ; 38(2-3): 133-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10642041

ABSTRACT

The diagnostic and prognostic significance of the absence of simple partial seizures (SPS) immediately preceding complex partial seizures (CPS) was examined in patients with temporal lobe epilepsy. The status of self-reported SPS in 193 patients with temporal lobe epilepsy who had surgical therapy more than 2 years ago was reviewed. Before surgery, 37 patients never experienced SPS before CPS (Group A), 156 patients either always or occasionally had SPS before CPS (Group B). The frequency of mesial temporal sclerosis (MTS) was lower and the age at onset of epilepsy was higher in Group A. The seizure focus was in the language-dominant temporal lobe in 73% of the cases in Group A, compared with 40% in Group B. The surgical outcome did not differ between the two groups. The findings suggest that temporal lobe seizures without preceding SPS tend to originate in the language-dominant temporal lobe that contains a pathologic etiology other than MTS, especially in the lateral temporal lobe. The surgical outcome in patients without SPS is similar to that in patients with SPS.


Subject(s)
Epilepsies, Partial , Epilepsy, Complex Partial/physiopathology , Epilepsy, Temporal Lobe/physiopathology , Adolescent , Adult , Aphasia/etiology , Brain Neoplasms/complications , Child , Child, Preschool , Deja Vu , Dominance, Cerebral , Electroencephalography , Epilepsy, Complex Partial/diagnosis , Epilepsy, Complex Partial/etiology , Epilepsy, Complex Partial/pathology , Epilepsy, Complex Partial/surgery , Epilepsy, Temporal Lobe/diagnosis , Epilepsy, Temporal Lobe/etiology , Epilepsy, Temporal Lobe/pathology , Epilepsy, Temporal Lobe/surgery , Humans , Infant , Intracranial Arteriovenous Malformations/complications , Language , Memory/physiology , Middle Aged , Prognosis , Sclerosis , Temporal Lobe/blood supply , Temporal Lobe/pathology , Temporal Lobe/physiopathology , Treatment Outcome
19.
Org Lett ; 2(26): 4197-9, 2000 Dec 28.
Article in English | MEDLINE | ID: mdl-11150198

ABSTRACT

The title compound has been synthesized as the first oligothiophenophane that has the typical stacking structure of a layered cyclophane and can behave as an ideal pi-dimer model.

20.
Hepatogastroenterology ; 46(29): 2919-24, 1999.
Article in English | MEDLINE | ID: mdl-10576373

ABSTRACT

BACKGROUND/AIMS: Patients who survive partial hepatectomy sometimes have unsatisfactory liver regeneration and restoration of liver function. Although the extent of resection should be adjusted to attain favorable liver regeneration and restoration of liver function, a guiding principle for this has not been established. METHODOLOGY: Seventy patients with hepatic tumors associated with liver disorders of various severity who underwent hepatectomy were studied. We calculated the removal rate of the liver and the regeneration rate of the remnant liver using computed tomography. The liver function was investigated using ICG R-15 (retention rate of indocyanine green). Liver disorder was classified into 4 groups, according to the severity of fibrosis. RESULTS: The regeneration rates of the remnant liver indicated a significant decline in patients with severe fibrosis. In the no fibrosis and mild fibrosis groups, an increased removal rate was associated with increased regeneration rate, and post-operative ICG R-15 improved with time. However, in the moderate fibrosis and severe fibrosis groups, an increased removal rate was not associated with increased regeneration rate, and post-operative ICG R-15 showed no change or became worse with time. CONCLUSIONS: Severe fibrosis of the liver parenchyma is associated with poorer regeneration of the remnant liver leading to poor restoration of post-operative liver function. The severity of fibrosis is useful as a predictive factor for liver regeneration and restoration of liver function after partial hepatectomy.


Subject(s)
Hepatectomy , Liver Function Tests , Liver Neoplasms/surgery , Liver Regeneration/physiology , Postoperative Complications/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , Female , Humans , Indocyanine Green , Liver/diagnostic imaging , Liver/pathology , Liver Cirrhosis/diagnostic imaging , Liver Cirrhosis/pathology , Male , Middle Aged , Postoperative Complications/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...